Information for Healthcare Providers
DIACOMIT® (stiripentol) is an effective, FDA-approved medication that was developed specifically to treat seizures associated with Dravet syndrome. It is indicated for patients 6 months and older (weighing 15 lb or more) taking clobazam. There are no clinical data to support the use of DIACOMIT as a monotherapy.1
Easier and Earlier Than Ever Before
With Biocodex By Your Side, it’s easier than ever to get a prescription filled for DIACOMIT. And with the latest FDA approval, patients can start treatment as early as 6 months old. DIACOMIT is available through our specialty pharmacy partner and covered by most insurance plans.
Patients pay an average of less than $3 for DIACOMIT.31
*Includes all commercial and government insurances
Working With Our Specialty Pharmacy Partner
Biocodex has partnered with a national specialty pharmacy that will handle most of the process and deliver DIACOMIT directly to your door. Our partnership is designed to remove access barriers for you and your patients. Everyone has a role to play to help ensure that your patient gets the treatment they need in as fast as one week.
Your role as a healthcare provider:
- Fax the specialty pharmacy required forms and information. (Review our checklist below.)
- Provide additional documents as required by insurance plans.
- Educate patients and caregivers about DIACOMIT and Dravet syndrome.
Your patient’s role
- Provide insurance information to the specialty pharmacy.
- Respond to phone calls to coordinate shipments.
- Inform the Biocodex By Your Side team of any changes to:
- Insurance coverage
- Healthcare providers
- Patient or caregiver contact information
The specialty pharmacy’s role:
- Dispense DIACOMIT (stiripentol).
- Process prescriptions and coordinate with insurance companies.
- Help with treatment access through savings and support programs.
- Educate patients and caregivers about medication management.
- Coordinate DIACOMIT shipment and delivery.
Putting Patients First
We aim to make our process as easy as possible, and we’re happy to provide the following services to assist you:
A dedicated Rare Care team that understands Dravet syndrome and DIACOMIT treatment so it can advocate for your patients.
A team ready to resolve issues with insurance coverage and prior authorization, so you don’t have to.
Pharmacists on call 24/7 and translation services in 100+ languages to answer your patients’ questions or concerns about their DIACOMIT prescription.
Convenient text message reminders (opt-in required) to keep your patients up to date on the status of their prescription and refill schedule.
Shipment tracking so your patients know when to expect their DIACOMIT delivery.
Our Patient Savings and Support Programs
Biocodex believes that those who need DIACOMIT should be able to get it, regardless of their financial status or insurance coverage. There are four patient programs in place to ensure that your patients can easily access treatment.
Quick Start Program:
- Up to 60-day fulfillment of DIACOMIT at no cost to the patient.
- For newly eligible patients experiencing delays in gaining access to treatment.
Bridge Program:
- Up to 60-day fulfillment of DIACOMIT at no cost to the patient.
- For current patients with changes or lapses in their insurance coverage.
Copay Program:
- $0 copay per prescription.
- For eligible patients with commercial insurance.
- Not available for government plans such as Medicare or Medicaid.
Long-Term Patient Assistance Program
- Prescription of DIACOMIT at no cost to the patient.
- For eligible patients who are uninsured or underinsured.
Ready to make the DIACOMITment?
You can start your patients on DIACOMIT in just three steps. You can save and make copies of this checklist by downloading our DIACOMIT Access Guide.
Fax the following to the specialty pharmacy at 833-871-4137
A completed Patient Enrollment Form.
A copy of your patient’s insurance card (front and back).
A prescription with clear dosing and titration instructions.
List of your patient’s current medications.
Your patient’s medical records.
Tip: Ensure your patient’s chart has a Dravet diagnosis code:
- Dravet syndrome (G40.83), polymorphic epilepsy in infancy (PMEI) or severe myoclonic epilepsy in infancy (SMEI)
- Dravet syndrome, intractable, with status epilepticus (G40.833)
- Dravet syndrome, intractable, without status epilepticus (G40.834)
Complete prior authorization request (if applicable)
Work with the specialty pharmacy to complete and submit required payer forms.
If needed, complete a letter of medical necessity.
If needed, complete a letter of appeal.
Stay connected and follow up
Notify your patient or their caregiver that the specialty pharmacy will reach out to coordinate shipment and delivery.
Save the Biocodex By Your Side number: 833-248-0467.
